Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D for Preventing Preeclampsia Recurrence
NCT07717931Phase 4Completed
- Sponsor
- CMH Multan Institute of Medical Sciences
- Start
- Aug 2025
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in preeclampsia comparing Vitamin D Supplementation with Placebo (2 arms). Primary endpoint: Recurrence of Preeclampsia. Started Aug 2025; status: completed.
02
Drugs
vitamin d
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT07717931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07717931.